In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune disease that was attacking Uresa’s body and suddenly and seriously affected her ability to lead a normal life.
This article was originally published on MedicalXpress.com